,75 Furthermore, we found that effector CD4+ T cells, particularly Tbet+ICOS+ Th1-like CD4+ T cells, were important for the remodeling of tumor vasculature and the increase of TA-HEVs during anti-CTLA-4 therapy in the MCAprog tumor model. This evidence concerns the gene CTLA4 and neoplasm.